|
⚲
|
| Superstring Capital Management LP
✚
| |
|---|---|
| CRD # | 305743 |
| SEC # | 801-118766 |
| CIK # | 0001931118 |
| AUM | $371.1 MM (2024-03-28) |
| Employees | 6 (67% Investors, 0% Brokers) |
| Phone | 212-257-5690 |
| Address | 150 E 52nd St New York, NY 10022 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($MM) |
|---|
| CIK | Period |
|---|---|
| 0001931118 | |
| / | |
| Sector | Form 13F Holdings | Cap ($MM) | Value ($MM) |
|---|---|---|---|
| Cytokinetics Inc | 4,051.3 | 10.2 | |
| Legend Biotech Corp | 8,114.0 | 6.9 | |
| Terns Pharmaceuticals Inc | 60.7 | 6.5 | |
| Bridgebio Pharma Inc | 1,284.9 | 5.6 | |
| 89bio Inc | 72.2 | 5.5 | |
| Nkarta Inc | 587.6 | 5.2 | |
| Zai Lab Ltd | 2,597.4 | 3.7 | |
| Keros Therapeutics Inc | 625.6 | 3.4 | |
| Arcellx Inc | 782.5 | 3.3 | |
| Arrowhead Research Corp | 3,433.3 | 2.9 | |
| Corbus Pharmaceuticals Holdings Inc | 33.8 | 2.6 | |
| BeiGene Ltd | 17,043.8 | 1.8 | |
| Fate Therapeutics Inc | 2,391.6 | 1.6 | |
| Allogene Therapeutics Inc | 1,648.5 | 1.6 | |
| Pyxis Oncology Inc | 75.2 | 1.6 | |
| Apogee Therapeutics Inc | 1.5 | ||
| CytomX Therapeutics Inc | 121.6 | 1.4 | |
| Newamsterdam Pharma Co NV | 1.2 | ||
| Talaris Therapeutics Inc | 1.2 | ||
| Novocure Ltd | 7,533.3 | 1.1 | |
| Aeglea Biotherapeutics Inc | 1.1 | ||
| Cabaletta Bio Inc | 30.1 | 1.0 | |
| BCTG Acquisition Corp | 387.6 | 1.0 | |
| Allakos Inc | 176.9 | 0.9 | |
| Adventrx Pharmaceuticals Inc | 172.2 | 0.8 | |
| Biomea Fusion Inc | 324.6 | 0.8 | |
| Zeta Acquisition Corp III | 1,163.5 | 0.7 | |
| JATT Acquisition Corp | 0.5 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold ($MM) | AUM ($MM) |
|---|---|---|---|---|
| PE | Superstring Private Opportunites Fund I LP | [2022-03-30] | 9.8 | 48.9 |
| HF | Superstring Capital Master Fund LP | [2019-10-18] | 63.6 | 258.5 |
| AUM Breakdown | Accounts | AUM ($MM) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 5 | 307.4 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 3 | 63.7 |
| Total | 8 | 371.1 |
| By Discretionary | ||
| Discretionary | 8 | 371.1 |
| Non-Discretionary | 0 | 0.0 |
| Total | 8 | 371.1 |
| By Non-United States Persons | ||
| Non-United States Persons | 147.1 | |
| United States Persons | 224.0 | |
| Total | 8 | 371.1 |
| Form D Directors | # Filings | # Firms | 2011 - 2024 |
|---|---|---|---|
| Patrick Agemian | 108 | ||
| Martin Lang | 156 | ||
| George Song | 5 | ||
| Superstring Capital Management LP | 4 | ||
| Superstring Capital Fund GP LLC | 3 | ||
| Ting Guo | 3 |
| EDGAR Form | CIK | 2011 - 2024 |
|---|---|---|
| 13F-HR | [0001931118] |
| Comparable Firms | State | AUM ($BB) |
|---|---|---|
|
Vedanta Management LP
✚
|
NY | 0.4 |
|
Abry Partners LLC
✚
|
MA | 0.4 |
|
Old Well Partners LLC
✚
|
NC | 0.4 |
|
Lago Asset Management LLC
✚
|
IL | 0.4 |
|
Wayzata Investment Partners LLC
✚
|
MN | 0.4 |
|
Melkonian Capital Management LLC
✚
|
NY | 0.4 |
|
Bennbridge US LLC
✚
|
MA | 0.4 |
|
Troob Capital Management LLC
✚
|
NY | 0.4 |
|
Chalkstream Capital Group LP
✚
|
NY | 0.4 |
|
Beringea LLC
✚
|
MI | 0.4 |